WebNephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. Sfunga Therapeutics and NephroDI Therapeutics share similar industries . Save These companies are similar. Aclaris Therapeutics . Malvern, Pennsylvania, United States 45 Contacts 101-250 employees . WebMay 12, 2024 · NephroDI Therapeutics: Developing a novel AMPK activator for the treatment of the congenital rare disease of Nephrogenic Diabetes Insipidus (NDI).
Xontogeny Seeds NephroDI to Develop a Treatment for …
WebMay 15, 2024 · Biolocity graduate company, NephroDI Therapeutics, recently raised $1.6M to advance the development of a treatment for Nephrogenic Diabetes Insipidus (NDI), a … WebMar 18, 2024 · About NephroDI Therapeutics. NephroDI Therapeutics is a pharmaceutical company that focuses on concentration disorders of the kidney. The initial clinical indication for its orally administered lead small molecule is for Nephrogenic Diabetes Insipidus in children, a pediatric orphan indication. Currently there is no effective therapy … cistern\\u0027s ip
NephroDI Therapeutics Company Profile: Valuation & Investors
WebNephroDI Therapeutics. Philadelphia, Pennsylvania, United States 1 Contact1-10 employees. Biopharma. Biotechnology. Health Care. NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. SparX Therapeutics and NephroDI Therapeutics share similar industries. These … WebNephroDI Therapeutics is a pre-clinical development stage biopharmaceutical company that focuses on concentration disorders of the kidney. The initial clinical indication for its … WebExplore NephroDI Therapeutics's investment information, scientific platforms, therapeutic approaches ... Explore NephroDI Therapeutics's investment information, scientific … diamond woodworking definition